Bahl & Gaynor’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $171M | Sell |
619,473
-11,067
| -2% | -$3.05M | 0.86% | 32 |
|
|
2025
Q1 | $167M | Buy |
630,540
+15,912
| +3% | +$4.22M | 0.85% | 35 |
|
|
2024
Q4 | $143M | Buy |
614,628
+57,439
| +10% | +$13.3M | 0.75% | 39 |
|
|
2024
Q3 | $123M | Buy |
557,189
+14,159
| +3% | +$3.12M | 0.63% | 46 |
|
|
2024
Q2 | $107M | Buy |
543,030
+46,714
| +9% | +$9.18M | 0.6% | 50 |
|
|
2024
Q1 | $107M | Buy |
496,316
+357,286
| +257% | +$76.9M | 0.59% | 51 |
|
|
2023
Q4 | $29.3M | Buy |
+139,030
| New | +$29.3M | 0.18% | 83 |
|
|
2020
Q3 | – | Sell |
-2,479
| Closed | -$403K | – | 333 |
|
|
2020
Q2 | $403K | Sell |
2,479
-3,845
| -61% | -$625K | ﹤0.01% | 295 |
|
|
2020
Q1 | $1.09M | Sell |
6,324
-25
| -0.4% | -$4.32K | 0.01% | 249 |
|
|
2019
Q4 | $1.27M | Sell |
6,349
-1,715
| -21% | -$344K | 0.01% | 265 |
|
|
2019
Q3 | $1.7M | Buy |
8,064
+161
| +2% | +$34K | 0.01% | 240 |
|
|
2019
Q2 | $1.53M | Buy |
+7,903
| New | +$1.53M | 0.01% | 249 |
|